Increased plasma levels of damage-associated molecular patterns during systemic anticancer therapy in patients with advanced lung cancer.
Inoue H, Tsutsumi H, Tanaka K, Iwama E, Shiraishi Y, Hirayama A, Nakanishi T, Ando H, Nakajima M, Shinozaki S, Ogata H, Uryu K, Okamura K, Kimura S, Ogawa T, Ota K, Yoneshima Y, Hamada N, Nakanishi Y, Okamoto I.
Inoue H, et al. Among authors: ogawa t.
Transl Lung Cancer Res. 2021 Jun;10(6):2475-2486. doi: 10.21037/tlcr-21-92.
Transl Lung Cancer Res. 2021.
PMID: 34295655
Free PMC article.